Devita, Hellman, and Rosenberg's Cancer

LWBK1006-02 LWW-Govindan-Review November 24, 2011 11:18

24 DeVita, Hellman, and Rosenberg’s CANCER: Principles and Practice of Oncology Review

Question 2.45. The drug vemurafenib (PLX4032) targets which gene in MAPK/ERK

pathway?

A. RAS

B. BRAF

C. BIM

D. ERK

Question 2.46. Which of the following agents targets tumor metabolic pathways?

A. Pemetrexed

B. Cytarabine

C. Temsirolimus

D. All of the above